CoChat

The anti-viral dynamin family member MxB participates in mitochondrial integrity

Open access
Cao, Hong, Krueger, E. W., Chen, Jing, Drizyte-Miller, Kristina, Schulz, Mary E., McNiven, Mark A. · 2020 · Nature Communications

The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.

Abstract

The membrane deforming dynamin family members MxA and MxB are large GTPases that convey resistance to a variety of infectious viruses. During viral infection, Mx proteins are known to show markedly increased expression via an interferon-responsive promoter to associate with nuclear pores. In this study we report that MxB is an inner mitochondrial membrane GTPase that plays an important role in the morphology and function of this organelle. Expression of mutant MxB or siRNA knockdown of MxB leads to fragmented mitochondria with disrupted inner membranes that are unable to maintain a proton gradient, while expelling their nucleoid-based genome into the cytoplasm. These findings implicate a dynamin family member in mitochondrial-based changes frequently observed during an interferon-based, anti-viral response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-14727-w

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 MxB is localized to mitochondria in cultured cells. Fluorescence images of Hep3B cells or HeLa cells, stained with a polyclonal antibody (IJ-GP) to MxB (a, c), or expressing exogenous human MxB-GFP (b, d). All cells were stained for the inner mitochondrial membrane marker CoxIV. MxB is visualized as small or large puncta that align closely with mitochondrial membranes. Boxed regions provide a higher magnification for color overlays showing the alignment of MxB (green) with mitochondria (red) in both cell types. Scale bars, 10 μm. e Western blot analysis of different human tissues (Br = brain, Lng = lung, Liv = liver, LN = lymph node, SP = spleen, Tst = testis, Tns = tonsil) for endogenous MxB that appears enriched in the liver, lymph node, testis, tonsil, and pig liver. f Western blotting comparing MxB expression in HeLa cells, three different hepatocyte cell lines, and a human monocyte cell line (THP-1), as well as primary human and pig hepatocytes. Expression levels are exceptionally high in primary hepatocytes, the HepG2 and Huh7 cell lines (H3B = Hep3B, HG2 = HepG2, Hu7 = Huh7, THP = THP-1, Hu = human hepatocytes). g Western blotting of four distinct cell lines comparing endogenous MxB expression under control conditions vs. treatment with 1,000 IU/ ml-1 of IFN-α−2Α. HeLa, Hep3B and HepG2 cells induced MxB expression by IFN treatment, but not Huh7 cells.
Fig. 1 MxB is localized to mitochondria in cultured cells. Fluorescence images of Hep3B cells or HeLa cells, stained with a polyclonal antibody (IJ-GP) to MxB (a, c), or expressing exogenous human MxB-GFP (b, d). All cells were stained for the inner mitochondrial membrane marker CoxIV. MxB is visualized as small or large puncta that align closely with mitochondrial membranes. Boxed regions provide a higher magnification for color overlays showing the alignment of MxB (green) with mitochondria (red) in both cell types. Scale bars, 10 μm. e Western blot analysis of different human tissues (Br = brain, Lng = lung, Liv = liver, LN = lymph node, SP = spleen, Tst = testis, Tns = tonsil) for endogenous MxB that appears enriched in the liver, lymph node, testis, tonsil, and pig liver. f Western blotting comparing MxB expression in HeLa cells, three different hepatocyte cell lines, and a human monocyte cell line (THP-1), as well as primary human and pig hepatocytes. Expression levels are exceptionally high in primary hepatocytes, the HepG2 and Huh7 cell lines (H3B = Hep3B, HG2 = HepG2, Hu7 = Huh7, THP = THP-1, Hu = human hepatocytes). g Western blotting of four distinct cell lines comparing endogenous MxB expression under control conditions vs. treatment with 1,000 IU/ ml-1 of IFN-α−2Α. HeLa, Hep3B and HepG2 cells induced MxB expression by IFN treatment, but not Huh7 cells.CC BY · PubMed Central
Fig. 2 MxB distribution in living cells is dynamic. a Time-lapse imaging of Hep3B cells expressing mCherry-MxB and viewed over a 16 h time period. Initially, MxB is diffuse in distribution, although condenses into several fine puncta by 5 h that subsequently dissolve but reform into much larger structures by 9 h. Surprisingly, these large aggregates also dissolve or disassemble several hours later (see Supplementary Movie 1). b, c Time-lapse imaging of Hep3B cells co-expressing mCherry-MxB (red) and Mito-GFP (white), and viewed over a 16 h time period to test for dynamic associations of MxB with mitochondria. Low-magnification images of cells show the tagged MxB changing from a diffuse to punctate, to diffuse distribution in close proximity of mitochondria. Higher magnification viewing (inserts) reveals that many of these formed puncta associate along or at the tips of the dynamic mitochondria (arrows) (see Supplementary Movies 2 and 3). Scale bars, 10 μm.
Fig. 2 MxB distribution in living cells is dynamic. a Time-lapse imaging of Hep3B cells expressing mCherry-MxB and viewed over a 16 h time period. Initially, MxB is diffuse in distribution, although condenses into several fine puncta by 5 h that subsequently dissolve but reform into much larger structures by 9 h. Surprisingly, these large aggregates also dissolve or disassemble several hours later (see Supplementary Movie 1). b, c Time-lapse imaging of Hep3B cells co-expressing mCherry-MxB (red) and Mito-GFP (white), and viewed over a 16 h time period to test for dynamic associations of MxB with mitochondria. Low-magnification images of cells show the tagged MxB changing from a diffuse to punctate, to diffuse distribution in close proximity of mitochondria. Higher magnification viewing (inserts) reveals that many of these formed puncta associate along or at the tips of the dynamic mitochondria (arrows) (see Supplementary Movies 2 and 3). Scale bars, 10 μm.CC BY · PubMed Central
Fig. 3 Manipulation of MxB expression induces marked changes in mitochondrial morphology. a, b Fluorescence micrographs of transfected Hep3B cells (outlined in white border) expressing either an untagged (a) or GFP-tagged (b) GTPase-defective K131A mutant of MxB. Transfected cells possess mitochondria that are fragmented or distorted, or exhibit attenuated staining with antibodies to CoxIV compared with adjacent untransfected cells. c Bar graph representing morphological changes of mitochondria in control, WT, or mutant (K131A) MxB-expressing cells. Morphologies of clustered, fragmented, deformed, or normal mitochondria were counted in images of 636 Hep3B cells from three distinct experiments. d Graph representing the mean percentage of cells exhibiting a reduced CoxIV staining from 636 control or MxB-transfected cells from three distinct experiments. e–g Electron micrographs of mitochondria from Hep3B cells transfected to express MxB WT or K131A. Control cells (e) possess mitochondria with normal cristae, while cells expressing WT (f) or mutant (K131A) MxB (g) display mitochondria with reduced cristae and dark membrane vesiculations in the matrix (arrowheads). Scale bars, 10 μm (a, b), 0.5 μm (e–g). h–o Reducing MxB levels by siRNA or shRNA treatment promotes mitochondrial fragmentation. h Western blot of Hep3B cells treated for 5 days with siRNA or shRNA to MxB shows reduced protein levels. i–k Immunofluorescence of control Hep3B cells (i) or cells treated with siRNA (j) or shRNA (k) to reduce endogenous MxB levels and stained for CoxIV. Both treatments induced a marked change in mitochondrial morphology. l Bar graph representing morphological changes of mitochondria from 568 Hep3B cells from three distinct experiments. m–o Electron microscopy of control NTsi (m) or siRNA MxB-treated cells showing fragmented mitochondria with vesiculated cristae (arrowheads) and large vacuoles (arrows). (c, d, l Data were analyzed using a two-tailed t-test, error bars indicate SD. Scale bars, 10 μm (i–k), 0.5 μm (m–o).
Fig. 3 Manipulation of MxB expression induces marked changes in mitochondrial morphology. a, b Fluorescence micrographs of transfected Hep3B cells (outlined in white border) expressing either an untagged (a) or GFP-tagged (b) GTPase-defective K131A mutant of MxB. Transfected cells possess mitochondria that are fragmented or distorted, or exhibit attenuated staining with antibodies to CoxIV compared with adjacent untransfected cells. c Bar graph representing morphological changes of mitochondria in control, WT, or mutant (K131A) MxB-expressing cells. Morphologies of clustered, fragmented, deformed, or normal mitochondria were counted in images of 636 Hep3B cells from three distinct experiments. d Graph representing the mean percentage of cells exhibiting a reduced CoxIV staining from 636 control or MxB-transfected cells from three distinct experiments. e–g Electron micrographs of mitochondria from Hep3B cells transfected to express MxB WT or K131A. Control cells (e) possess mitochondria with normal cristae, while cells expressing WT (f) or mutant (K131A) MxB (g) display mitochondria with reduced cristae and dark membrane vesiculations in the matrix (arrowheads). Scale bars, 10 μm (a, b), 0.5 μm (e–g). h–o Reducing MxB levels by siRNA or shRNA treatment promotes mitochondrial fragmentation. h Western blot of Hep3B cells treated for 5 days with siRNA or shRNA to MxB shows reduced protein levels. i–k Immunofluorescence of control Hep3B cells (i) or cells treated with siRNA (j) or shRNA (k) to reduce endogenous MxB levels and stained for CoxIV. Both treatments induced a marked change in mitochondrial morphology. l Bar graph representing morphological changes of mitochondria from 568 Hep3B cells from three distinct experiments. m–o Electron microscopy of control NTsi (m) or siRNA MxB-treated cells showing fragmented mitochondria with vesiculated cristae (arrowheads) and large vacuoles (arrows). (c, d, l Data were analyzed using a two-tailed t-test, error bars indicate SD. Scale bars, 10 μm (i–k), 0.5 μm (m–o).CC BY · PubMed Central
Fig. 4 MxB resides within the mitochondrial matrix and is essential for normal mitochondrial function. a Western blot analysis of MxB distribution observed by subsequent steps of biochemical mitochondrial enrichment from pig liver. Fractions include: homogenate (Hom), a nuclear pellet (Nucl), a crude mitochondria fraction (Crude), a pure mitochondria fraction (pure), a cytosolic fraction (Cyto), and the endoplasmic reticulum (ER); all fractions were probed with marker antibodies to the mitochondria (CoxIV), actin, endoplasmic reticulum (Calnexin), and Golgi (GM130). Equal protein loads were used for each lane. b Western blot analysis of a mitochondria protease protection assay. A freshly isolated, enriched, mitochondria fraction from pig livers was treated with 0, 0.2, or 1 mg ml−1 of trypsin for 20 min, then probed with antibodies to MxB, or the mitochondrial proteins OPA1, Tom20, and CoxIV. MxB and respiratory complex enzyme CoxIV appear resistant to the higher levels (1.0 mg ml−1) of trypsin, whereas Tom20 and OPA1 are digested. c–g APEX2-based EM of the mitochondria in Hep3B cells. EMs of Hep3B cells exposed to transfection reagent as a control (c) or transfected to express either WT MxB (d, e) or mutant (K131A) MxB (f, g) fused to APEX2. Mitochondria in control cells show normal staining and structure, whereas WT MxB-expressing cells (d, e) exhibit prominent labeling of nuclear pores (arrow heads) and mitochondrial membranes (arrows). Mitochondrial cristae staining also appear reduced in these organelles. In contrast, mitochondria of MxB mutant-expressing cells (f, g) are darkly labeled throughout with exceptionally dark staining regions observed along the cristae (arrows) and in the matrix. These organelles also display vacuoles, protrusions, and disordered cristae. h HeLa cells and Hep3B cells (i) were co-transfected to express the mutant MxB K131A protein and a Mito-GFP marker or co-stained for CoxIV. Cells were fixed and stained for MxB. Both cell types showed an increased colocalization of the mutant MxB with mitochondria compared with WT protein. Scale bars, 0.5 μm (c–g), 10 μm (h, i).
Fig. 4 MxB resides within the mitochondrial matrix and is essential for normal mitochondrial function. a Western blot analysis of MxB distribution observed by subsequent steps of biochemical mitochondrial enrichment from pig liver. Fractions include: homogenate (Hom), a nuclear pellet (Nucl), a crude mitochondria fraction (Crude), a pure mitochondria fraction (pure), a cytosolic fraction (Cyto), and the endoplasmic reticulum (ER); all fractions were probed with marker antibodies to the mitochondria (CoxIV), actin, endoplasmic reticulum (Calnexin), and Golgi (GM130). Equal protein loads were used for each lane. b Western blot analysis of a mitochondria protease protection assay. A freshly isolated, enriched, mitochondria fraction from pig livers was treated with 0, 0.2, or 1 mg ml−1 of trypsin for 20 min, then probed with antibodies to MxB, or the mitochondrial proteins OPA1, Tom20, and CoxIV. MxB and respiratory complex enzyme CoxIV appear resistant to the higher levels (1.0 mg ml−1) of trypsin, whereas Tom20 and OPA1 are digested. c–g APEX2-based EM of the mitochondria in Hep3B cells. EMs of Hep3B cells exposed to transfection reagent as a control (c) or transfected to express either WT MxB (d, e) or mutant (K131A) MxB (f, g) fused to APEX2. Mitochondria in control cells show normal staining and structure, whereas WT MxB-expressing cells (d, e) exhibit prominent labeling of nuclear pores (arrow heads) and mitochondrial membranes (arrows). Mitochondrial cristae staining also appear reduced in these organelles. In contrast, mitochondria of MxB mutant-expressing cells (f, g) are darkly labeled throughout with exceptionally dark staining regions observed along the cristae (arrows) and in the matrix. These organelles also display vacuoles, protrusions, and disordered cristae. h HeLa cells and Hep3B cells (i) were co-transfected to express the mutant MxB K131A protein and a Mito-GFP marker or co-stained for CoxIV. Cells were fixed and stained for MxB. Both cell types showed an increased colocalization of the mutant MxB with mitochondria compared with WT protein. Scale bars, 0.5 μm (c–g), 10 μm (h, i).CC BY · PubMed Central
Fig. 5 Expression of MxB disrupts mitochondrial function and genome stability. a–f Mitochondria in MxB-expressing cells exhibit loss of the proton gradient. Fluorescence micrographs of Hep3B cells that were transfected to express either pmCherry-N1 Vector, MxB WT-pmCherry, the MxB-pmCherry K131A mutant, or exposed to siRNA treatment for 5 days followed by incubation with 50 nM of the proton-gradient sensing dye Rho123. Transfected cells (white outlines) show modest mitochondrial fluorescence, indicating a metabolic impairment. f Graph quantification of the effects of MxB expression or siRNA knockdown on mitochondrial function (n = 529 cells over 3 independent experiments). g–n Release of the mitochondrial genome (mtDNA) into the cytoplasm in MxB-manipulated cells. Fluorescence micrographs of Hep3B cells treated for 5 days with control vectors and either siRNA or shRNA to reduce endogenous levels of MxB, OPA1, or both MxB and OPA1. Cells were then fixed and stained for mitochondrial DNA nucleoids (green) and CoxIV (red). Each manipulation shows low magnifications of representative cells with corresponding high-magnification images of boxed regions. Control-treated cells (g, j) exhibited close alignment of DNA with mitochondria, whereas siRNA- or shRNA- treated cells resulted in fragmented mitochondria and a significant number of DNA puncta residing in the cytoplasm (h, k). In comparison, OPA1 KD cells displayed shorter mitochondria with DNA nucleoids at the tips (i). l Fluorescence quantification of mtDNA loss into the cytoplasm under different treatment conditions. The Y-axis reflects relative amount of mtDNA outside the mitochondria (n = 244 microscopic fields over 4 independent experiments). m, n Graphs depicting quantitative PCR of either total cellular mtDNA (m) or cytosolic (n) mtDNA. Mean fold change in mtDNA copy number between NTsi, MxB, OPA1, and MxB/ OPA1 siRNA-treated cells was measured by qPCR using a mitochondrial D-loop primer set (m, n; n = 3 independent experiments). Data were analyzed using a two-tailed t-test, error bars represent SD. l NTsi vs. MxBsi, OPA1si, MxBsi /OPA1si, TRC2 vs. shRNA#44: all P < 0.0001, OPA1si vs. MxBsi/OPA1si: P = 0.0007; NS, not significant (P = 0.1827). m NTsi vs. MxBsi: P = 0.00082, OPA1si: P = 0.00069, MxB/OPA1si: P = 0.00023. n NTsi vs. MxBsi: P = 0.0027, OPA1si: NS (P = 0.2334), MxB/OPA1si P = 0.00305. Scale bars, 10 μm.
Fig. 5 Expression of MxB disrupts mitochondrial function and genome stability. a–f Mitochondria in MxB-expressing cells exhibit loss of the proton gradient. Fluorescence micrographs of Hep3B cells that were transfected to express either pmCherry-N1 Vector, MxB WT-pmCherry, the MxB-pmCherry K131A mutant, or exposed to siRNA treatment for 5 days followed by incubation with 50 nM of the proton-gradient sensing dye Rho123. Transfected cells (white outlines) show modest mitochondrial fluorescence, indicating a metabolic impairment. f Graph quantification of the effects of MxB expression or siRNA knockdown on mitochondrial function (n = 529 cells over 3 independent experiments). g–n Release of the mitochondrial genome (mtDNA) into the cytoplasm in MxB-manipulated cells. Fluorescence micrographs of Hep3B cells treated for 5 days with control vectors and either siRNA or shRNA to reduce endogenous levels of MxB, OPA1, or both MxB and OPA1. Cells were then fixed and stained for mitochondrial DNA nucleoids (green) and CoxIV (red). Each manipulation shows low magnifications of representative cells with corresponding high-magnification images of boxed regions. Control-treated cells (g, j) exhibited close alignment of DNA with mitochondria, whereas siRNA- or shRNA- treated cells resulted in fragmented mitochondria and a significant number of DNA puncta residing in the cytoplasm (h, k). In comparison, OPA1 KD cells displayed shorter mitochondria with DNA nucleoids at the tips (i). l Fluorescence quantification of mtDNA loss into the cytoplasm under different treatment conditions. The Y-axis reflects relative amount of mtDNA outside the mitochondria (n = 244 microscopic fields over 4 independent experiments). m, n Graphs depicting quantitative PCR of either total cellular mtDNA (m) or cytosolic (n) mtDNA. Mean fold change in mtDNA copy number between NTsi, MxB, OPA1, and MxB/ OPA1 siRNA-treated cells was measured by qPCR using a mitochondrial D-loop primer set (m, n; n = 3 independent experiments). Data were analyzed using a two-tailed t-test, error bars represent SD. l NTsi vs. MxBsi, OPA1si, MxBsi /OPA1si, TRC2 vs. shRNA#44: all P < 0.0001, OPA1si vs. MxBsi/OPA1si: P = 0.0007; NS, not significant (P = 0.1827). m NTsi vs. MxBsi: P = 0.00082, OPA1si: P = 0.00069, MxB/OPA1si: P = 0.00023. n NTsi vs. MxBsi: P = 0.0027, OPA1si: NS (P = 0.2334), MxB/OPA1si P = 0.00305. Scale bars, 10 μm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 78 references

Cited by

See all 26

Metadata

Authors
Cao, H., Krueger, E. W., Chen, J., Drizyte-Miller, K., Schulz, M. E., & McNiven, M. A.
Affiliations
Mayo Clinic (US)
Corresponding author
McNiven, Mark A.
Venue
Nature Communications
Published
2020-02-26
Volume
11
Issue
1
Pages
1048-1048
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3008363451
Cited by
25
References
79
Citations by year
2026: 3 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 6 · 2021: 9 · 2020: 1
FWCI
1.66
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK P30DK084567)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords
MxB, MxA, dynamin-related GTPase, mitochondrial integrity, mitochondrial morphology, inner mitochondrial membrane, mitochondrial membrane potential, mitochondrial DNA release, interferon response, antiviral defense, mitochondrial fragmentation
MeSH terms
DNA, Mitochondrial, HeLa Cells, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Mitochondria, Hepatocytes, Dynamins, RNA Interference, RNA, Small Interfering, Cell Line, Tumor, Mitochondrial Membranes, Myxovirus Resistance Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The anti-viral dynamin family member MxB participates in mitochondrial integrity. https://app.cochat.ai/papers/10.1038/s41467-020-14727-w
The paper
Cao, H., Krueger, E. W., Chen, J., Drizyte-Miller, K., Schulz, M. E., & McNiven, M. A. (2020). The anti-viral dynamin family member MxB participates in mitochondrial integrity. Nature Communications. https://doi.org/10.1038/s41467-020-14727-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.